Cargando…
Advances in the Treatment of Mucoepidermoid Carcinoma
Mucoepidermoid carcinoma (MEC) represents 10-15% of salivary neoplasms. Due to their low incidence, it is challenging to conduct clinical trials and develop treatment guidelines. Although surgery is the most common approach for a resectable tumor, various treatment options such as chemotherapy, radi...
Autores principales: | Sama, Srikar, Komiya, Takefumi, Guddati, Achuta Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913015/ https://www.ncbi.nlm.nih.gov/pubmed/35317327 http://dx.doi.org/10.14740/wjon1412 |
Ejemplares similares
-
Unusual Synchronous Lung Tumors: Mucoepidermoid Carcinoma and Mucinous Adenocarcinoma
por: Ponea, Ana M., et al.
Publicado: (2014) -
Recent trends in use of adjuvant chemotherapy in elderly stage II–III non-small cell lung cancer
por: Komiya, Takefumi, et al.
Publicado: (2020) -
Analysis of Trends in Mortality in Patients with Lymphoepithelial Carcinoma of the Head and Neck
por: Picon, Hector, et al.
Publicado: (2021) -
Tumor Dormancy: Biologic and Therapeutic Implications
por: Balayan, Vanshika, et al.
Publicado: (2022) -
Infections in Hospitalized Cancer Patients
por: Delgado, Amanda, et al.
Publicado: (2021)